Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Journal of Clinical Medicine|December 23, 2023
Anti-SARS-CoV-2 Antibody Testing: Role and IndicationsSylvia Mink, Peter FraunbergerClinical Chemistry and Laboratory Medicine|February 13, 2024
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic reviewSylvia Mink, Patrick Reimann, Peter FraunbergerThe Lancet. Infectious Diseases|September 11, 2025
Autoantibodies in long COVID: a systematic reviewFabian Wilhelm, Janne Cadamuro, Sylvia MinkTransfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|August 13, 2024
Regulation of the Lewis Blood Group Antigen Expression: A Literature Review Supplemented with Computational AnalysisMartin Wipplinger, Sylvia Mink, Maike Bublitz, et al.Reviews in Medical Virology|February 24, 2025
Anti-SARS-CoV-2 Antibodies in Long-COVID-Markers of Protection or Elevated Risk? A Systematic ReviewSylvia Mink, Fabian Wilhelm, Janne Cadamuro, et al.Journal of Clinical Medicine|August 12, 2023
Association between Lipid Levels, Anti-SARS-CoV-2 Spike Antibodies and COVID-19 Mortality: A Prospective Cohort StudySylvia Mink, Christoph H Saely, Matthias Frick, et al.The Oncologist|July 23, 2025
Exploring the Impact of first-line Durvalumab plus chemotherapy on advanced biliary tract cancer: A Systematic Review and Meta-AnalysisPatrick Reimann, Eva-Maria Schneider, Angela Djanani, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 23, 2024
Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort studySylvia Mink, Heinz Drexel, Andreas Leiherer, et al.Scientific Reports|October 26, 2023
Anti-SARS-CoV-2 antibody levels predict outcome in COVID-19 patients with type 2 diabetes: a prospective cohort studySylvia Mink, Christoph H Saely, Andreas Leiherer, et al.International Journal of Molecular Sciences|May 25, 2024
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus IncidenceAndreas Leiherer, Axel Muendlein, Sylvia Mink, et al.Pageof 3